Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend

Investopedia

01-24

Key Takeaways

Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.
Both earnings and revenue exceeded analysts' forecasts on what CEO Gail Boudreaux called "tangible progress in improving our operations."
Elevance booted its quarterly dividend $0.08 to $1.71 per share.

Shares of Elevance Health (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on higher premiums, acquisitions, and growth of its pharmacy coverage unit. It also raised its dividend.

The company posted fourth-quarter adjusted earnings per share (EPS) of $3.84, with operating revenue up 6% year-over-year to $45.0 billion. Both exceeded analysts' estimates compiled by Visible Alpha.

Revenue at the Health Benefits segment gained 3% to $37.6 billion, driven by rising premium yields. Revenue for the Carelon division climbed 19% to $14.7 billion on the "launch and growth of risk-based capabilities in Carelon Services and acquisitions completed in 2024."

CEO Touts 'Tangible Progress in Improving Our Operations'

CEO Gail Boudreaux said the performance demonstrates "tangible progress in improving our operations in response to the dynamic environment facing the industry."

Elevance announced it would increase its quarterly per-share dividend to $1.71 from $1.63. The first-quarter dividend is payable on March 25 to shareholders of record at the close of business on March 10.

Despite today’s roughly 3% rise, Elevance Health shares are down about 15% in the last year.

TradingView

Do you have a news tip for Investopedia reporters? Please email us at

tips@investopedia.com

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2505004324"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2505004324\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2505004324?lang=zh_TW&edition=fundamental","thumbnail":"https://www.investopedia.com/thmb/iK7sS55V5b6OxqGuGCmbtvftCr0=/5000x3333/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2185760729-c2d82d67121b4e7b858adb2ddd0f75a7.jpg","is_english":true,"pubTime":"2025-01-24 00:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2505004324","market":"fut","top_or_hot":-1,"title":"Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend","media":"Investopedia","content":"<html><body><div><div><div><h3>Key Takeaways</h3>\n<div><ul><li><a href=\"https://laohu8.com/S/ELV\">Elevance Health</a> reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.</li><li>Both earnings and revenue exceeded analysts' forecasts on what CEO Gail Boudreaux called \"tangible progress in improving our operations.\"</li><li>Elevance booted its quarterly dividend $0.08 to $1.71 per share.</li></ul></div></div></div>\n<p> Shares of Elevance Health (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on higher premiums, acquisitions, and growth of its pharmacy coverage unit. It also raised its dividend.\n</p>\n<div></div>\n<p> The company posted fourth-quarter adjusted earnings per share (EPS) of $3.84, with operating revenue up 6% year-over-year to $45.0 billion.<span></span> Both exceeded analysts' estimates compiled by Visible Alpha.\n</p>\n<div></div>\n<p> Revenue at the Health Benefits segment gained 3% to $37.6 billion, driven by rising premium yields. Revenue for the Carelon division climbed 19% to $14.7 billion on the \"launch and growth of risk-based capabilities in Carelon Services and acquisitions completed in 2024.\"\n</p>\n<div></div>\n<span></span><h2> <span> CEO Touts 'Tangible Progress in Improving Our Operations' </span> </h2>\n<p> CEO Gail Boudreaux said the performance demonstrates \"tangible progress in improving our operations in response to the dynamic environment facing the industry.\"<span></span>\n</p>\n<div></div>\n<p> Elevance announced it would increase its quarterly per-share dividend to $1.71 from $1.63. The first-quarter dividend is payable on March 25 to shareholders of record at the close of business on March 10.\n</p>\n<div></div>\n<p> Despite today’s roughly 3% rise, Elevance Health shares are down about 15% in the last year.\n</p>\n<div></div>\n<figure> <div>\n<div>\n<img height=\"811\" width=\"1542\"/>\n<noscript>\n<img height=\"811\" sizes=\"750px\" src=\"https://www.investopedia.com/thmb/7AUFCnAYuRW4zlg74KoJNUhaLgU=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/ELV_2025-01-23_09-43-34-1736ee9fcf33439a97af8c32e819f724.png\" srcset=\"https://www.investopedia.com/thmb/9Ku1MWJXvyN0dNw61TUWty2mCQo=/750x0/filters:no_upscale():max_bytes(150000):strip_icc()/ELV_2025-01-23_09-43-34-1736ee9fcf33439a97af8c32e819f724.png 750w\" width=\"1542\"/>\n</noscript>\n</div> </div>\n<figcaption> <span><p>TradingView</p></span>\n</figcaption></figure>\n<div><div>Do you have a news tip for Investopedia reporters? Please email us at</div>\n<span>tips@investopedia.com</span></div></div></body></html>","source":"investopedia_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElevance Health Stock Rises as Company Tops Estimates, Raises Dividend\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Investopedia</strong><span class=\"h-time small\">2025-01-24 00:18</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div><div><div><h3>Key Takeaways</h3>\n<div><ul><li><a href=\"https://laohu8.com/S/ELV\">Elevance Health</a> reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.</li><li>Both earnings and revenue exceeded analysts' forecasts on what CEO Gail Boudreaux called \"tangible progress in improving our operations.\"</li><li>Elevance booted its quarterly dividend $0.08 to $1.71 per share.</li></ul></div></div></div>\n<p> Shares of Elevance Health (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on higher premiums, acquisitions, and growth of its pharmacy coverage unit. It also raised its dividend.\n</p>\n<div></div>\n<p> The company posted fourth-quarter adjusted earnings per share (EPS) of $3.84, with operating revenue up 6% year-over-year to $45.0 billion.<span></span> Both exceeded analysts' estimates compiled by Visible Alpha.\n</p>\n<div></div>\n<p> Revenue at the Health Benefits segment gained 3% to $37.6 billion, driven by rising premium yields. Revenue for the Carelon division climbed 19% to $14.7 billion on the \"launch and growth of risk-based capabilities in Carelon Services and acquisitions completed in 2024.\"\n</p>\n<div></div>\n<span></span><h2> <span> CEO Touts 'Tangible Progress in Improving Our Operations' </span> </h2>\n<p> CEO Gail Boudreaux said the performance demonstrates \"tangible progress in improving our operations in response to the dynamic environment facing the industry.\"<span></span>\n</p>\n<div></div>\n<p> Elevance announced it would increase its quarterly per-share dividend to $1.71 from $1.63. The first-quarter dividend is payable on March 25 to shareholders of record at the close of business on March 10.\n</p>\n<div></div>\n<p> Despite today’s roughly 3% rise, Elevance Health shares are down about 15% in the last year.\n</p>\n<div></div>\n<figure> <div>\n<div>\n<img height=\"811\" width=\"1542\"/>\n<noscript>\n<img height=\"811\" sizes=\"750px\" src=\"https://www.investopedia.com/thmb/7AUFCnAYuRW4zlg74KoJNUhaLgU=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/ELV_2025-01-23_09-43-34-1736ee9fcf33439a97af8c32e819f724.png\" srcset=\"https://www.investopedia.com/thmb/9Ku1MWJXvyN0dNw61TUWty2mCQo=/750x0/filters:no_upscale():max_bytes(150000):strip_icc()/ELV_2025-01-23_09-43-34-1736ee9fcf33439a97af8c32e819f724.png 750w\" width=\"1542\"/>\n</noscript>\n</div> </div>\n<figcaption> <span><p>TradingView</p></span>\n</figcaption></figure>\n<div><div>Do you have a news tip for Investopedia reporters? Please email us at</div>\n<span>tips@investopedia.com</span></div></div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.investopedia.com/elevance-health-stock-rises-as-company-tops-estimates-raises-dividend-8779010\">Investopedia</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1506573853.SGD","symbol_name":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","start_time":0,"source_url":"https://www.investopedia.com/elevance-health-stock-rises-as-company-tops-estimates-raises-dividend-8779010","article_id":"2505004324","we_media_id":null,"thumbnails":["https://www.investopedia.com/thmb/iK7sS55V5b6OxqGuGCmbtvftCr0=/5000x3333/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2185760729-c2d82d67121b4e7b858adb2ddd0f75a7.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2505004324","pubTimestamp":1737649130,"columns":[],"sourceInfo":{"source_id":"investopedia_highlight","name":"Investopedia"},"weMediaInfo":null,"summary":"Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.Both earnings and revenue exceeded analysts' forecasts on what CEO Gail Boudreaux called \"tangible progress in improving our operations.\"Elevance booted its quarterly dividend $0.08 to $1.71 per share.Shares of Elevance Health  advanced Thursday after the health insurance provider reported better-than-anticipated results on higher premiums, acquisitions, and growth of its pharmacy coverage unit. It also raised its dividend.The company posted fourth-quarter adjusted earnings per share  of $3.84, with operating revenue up 6% year-over-year to $45.0 billion. Both exceeded analysts' estimates compiled by Visible Alpha.Revenue at the Health Benefits segment gained 3% to $37.6 billion, driven by rising premium yields. Revenue for the Carelon division climbed 19% to $14.7 billion on the \"launch and growth of risk-based capabili","collect":0,"end_time":0,"defaultTopTitle":"investopedia.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU2430703178.SGD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (SGDHDG) INC","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","SG9999001077.SGD":"United International Growth Fund SGD","LU2244417387.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) ACC","LU0068578508.USD":"First Eagle Amundi International Cl AU-C USD","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0061474960.USD":"天利环球焦点基金AU Acc","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2592432038.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"A\" (USD) ACC","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","LU0251142724.SGD":"Fidelity America A-SGD","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","BK4585":"ETF&股票定投概念","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","LU2505996681.GBP":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (GBPHDG) INC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU0122379950.USD":"贝莱德世界健康科学A2","LU2505996509.AUD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (AUDHDG) INC","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU0985489474.SGD":"First Eagle Amundi International AHS-C SGD-H","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","LU1815333072.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"AUP\" (USD) INC","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","ELV":"Elevance Health","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4588":"碎股","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","BK4154":"管理型保健护理","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU0557290698.USD":"施罗德环球可持续增长基金","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","LU0187121727.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC"},"translate_title":"Elevance Health股价上涨，公司超出预期并提高股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1},"content_text":"Key Takeaways\nElevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.Both earnings and revenue exceeded analysts' forecasts on what CEO Gail Boudreaux called \"tangible progress in improving our operations.\"Elevance booted its quarterly dividend $0.08 to $1.71 per share.\n Shares of Elevance Health (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on higher premiums, acquisitions, and growth of its pharmacy coverage unit. It also raised its dividend.\n\n\n The company posted fourth-quarter adjusted earnings per share (EPS) of $3.84, with operating revenue up 6% year-over-year to $45.0 billion. Both exceeded analysts' estimates compiled by Visible Alpha.\n\n\n Revenue at the Health Benefits segment gained 3% to $37.6 billion, driven by rising premium yields. Revenue for the Carelon division climbed 19% to $14.7 billion on the \"launch and growth of risk-based capabilities in Carelon Services and acquisitions completed in 2024.\"\n\n\n  CEO Touts 'Tangible Progress in Improving Our Operations'  \n CEO Gail Boudreaux said the performance demonstrates \"tangible progress in improving our operations in response to the dynamic environment facing the industry.\"\n\n\n Elevance announced it would increase its quarterly per-share dividend to $1.71 from $1.63. The first-quarter dividend is payable on March 25 to shareholders of record at the close of business on March 10.\n\n\n Despite today’s roughly 3% rise, Elevance Health shares are down about 15% in the last year.\n\n\n \n\n\n\n\n\n \n TradingView\n\nDo you have a news tip for Investopedia reporters? Please email us at\ntips@investopedia.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}